Ultragenyx Pharma (RARE) Misses Q3 EPS by 11c

November 7, 2016 4:36 PM EST
Get Alerts RARE Hot Sheet
Trade RARE Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Ultragenyx Pharma (NASDAQ: RARE) reported Q3 EPS of ($1.64), $0.11 worse than the analyst estimate of ($1.53).

For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment